PMID- 36033112 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220830 IS - 2155-0417 (Electronic) IS - 2155-0417 (Linking) VI - 12 IP - 4 DP - 2021 TI - Pharmacogenomics Testing Confirmation of Carbamazepine Induced DRESS Reaction of an HLA-A*31:01 Positive, Polypharmacy Patient. LID - 10.24926/iip.v12i4.4341 [doi] AB - Pharmacogenomics (PGx) melds well with polypharmacy as another tool to identify medication related problems (MRPs) more specifically so they may be solved most effectively. PGx can pre-emptively assist in medication selection, medication dosing or identify better medications for patients already taking a medication. PGx can also confirm suspect medications of causing MRPs such as adverse drug reactions (ADRs) or drug interactions. In this case, PGx testing confirmed presence of a serious human leukocyte antigen (HLA) drug reaction with eosinophilia and systemic symptoms (DRESS) after a suspect medication had been stopped. CI - (c) Individual authors. FAU - Speicher, Leigh AU - Speicher L AD - General Internal Medicine, Mayo Clinic Florida; Contribution: writing, clinical resource. FAU - Crosby, Sheena AU - Crosby S AD - Ambulatory Pharmacist, Mayo Clinic Florida; Contribution: writing, review. FAU - Schuh, Michael J AU - Schuh MJ AD - Family Medicine, and Palliative Medicine, Mayo Clinic Florida; Contribution: concept, writing, clinical resource, review, editing. LA - eng PT - Journal Article DEP - 20210922 PL - United States TA - Innov Pharm JT - Innovations in pharmacy JID - 101574764 PMC - PMC9401381 OTO - NOTNLM OT - DRESS OT - HLA OT - collaboration OT - pharmacogenomics OT - polypharmacy EDAT- 2022/08/30 06:00 MHDA- 2022/08/30 06:01 PMCR- 2021/09/22 CRDT- 2022/08/29 04:50 PHST- 2022/08/29 04:50 [entrez] PHST- 2022/08/30 06:00 [pubmed] PHST- 2022/08/30 06:01 [medline] PHST- 2021/09/22 00:00 [pmc-release] AID - 10.24926/iip.v12i4.4341 [doi] PST - epublish SO - Innov Pharm. 2021 Sep 22;12(4):10.24926/iip.v12i4.4341. doi: 10.24926/iip.v12i4.4341. eCollection 2021.